ValueAct Capital Partners → NTR
ValueAct Capital holds 1.5% of Nutrien Ltd..
SEC source
Frequently asked questions
What stake does ValueAct Capital Partners hold in NTR?
ValueAct Capital Partners (ValueAct Capital) holds 1.5% of Nutrien Ltd. (NTR) via 13D filed 2024-07-29. Initial filing date: 2024-07-29. Active campaign — fund publicly seeks operational or governance changes.
What is ValueAct Capital Partners's thesis for NTR?
Improve capital allocation, explore potash/nitrogen business separation. Constructive-activism posture typical of ValueAct.
What's the difference between 13D and 13G filings?
Both are filed when a fund crosses 5% ownership of a public company. SCHEDULE 13D = active intent (the fund plans to influence management, board, M&A, or capital allocation). SCHEDULE 13G = passive intent (long-term position, no active influence). 13D filings carry stricter disclosure (10-day window from purchase); 13G is for long-only managers + index funds. NTR filing type: 13D.
Where does HoldLens get activist filing data?
SEC EDGAR Schedule 13D and 13G filings (10-day disclosure window for 13D; 45-day initial window for 13G then amendments as positions change). HoldLens federates campaigns across tracked activist funds and computes stake-change deltas over time. See /methodology for the full source list.
Data sourced from SEC EDGAR 13D / 13G filings. Activist intent and outcome reflect public disclosures and announcements only. Not investment advice.